Amdocs (DOX) Stock Price

Amdocs Price

NASDAQ·CLOSED
61.40USD+0.50 (+0.82 %)
Market closed

Over the last 19 years Amdocs grew revenue by 3.2% annually, reaching 4.53 B USD. Earnings per share have grown at 7.0% per year over the last 19 years. For Amdocs, the net margin of 12.5% is down versus 16.1% a few years ago. At today's price the dividend yield works out to roughly 3.43%. The payout ratio is around 41% of earnings. The dividend has grown at 17.5% per year over the past 13 years. The consensus 12-month price target for Amdocs is 98.94 USD, about 61.1% above where the stock trades today. Of 12 analysts, 10 rate the stock a buy — an overall Buy consensus. Amdocs's share price has lost 30.5% over the last twelve months. The stock trades about 23% above its 52-week low.

Amdocs stock price

Volume
Ex-Dividend
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of Amdocs over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Amdocs stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Amdocs's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Amdocs Stock Price History
DateAmdocs Price
8/21/202661.40 USD
8/20/202660.90 USD
8/19/202660.78 USD
8/18/202657.99 USD
8/14/202658.22 USD
8/13/202658.66 USD
8/12/202657.28 USD
8/11/202657.49 USD
8/10/202658.34 USD
8/7/202658.55 USD
8/6/202659.12 USD
8/5/202655.63 USD
8/4/202655.74 USD
8/3/202655.37 USD
7/31/202655.72 USD
7/30/202655.28 USD
7/29/202656.61 USD
7/27/202653.83 USD
7/23/202650.85 USD
7/22/202651.22 USD
7/21/202651.61 USD
7/20/202653.19 USD
7/17/202652.63 USD
7/16/202652.91 USD
7/15/202651.56 USD
7/14/202651.96 USD
7/13/202652.79 USD
7/10/202651.91 USD
7/9/202651.99 USD
7/8/202651.78 USD
7/7/202652.29 USD
7/6/202651.89 USD
7/2/202651.75 USD
7/1/202651.18 USD
6/30/202650.54 USD
6/29/202651.42 USD
6/26/202651.97 USD
6/25/202649.87 USD
6/24/202651.65 USD
6/23/202652.35 USD
6/22/202650.48 USD
6/18/202652.43 USD
6/17/202655.78 USD
6/16/202656.14 USD
6/15/202656.49 USD
6/12/202657.10 USD
6/11/202655.54 USD
6/10/202657.75 USD
6/9/202657.98 USD
6/8/202658.34 USD
6/5/202660.53 USD
6/4/202660.95 USD
6/3/202660.40 USD
6/2/202662.69 USD
6/1/202664.46 USD
5/29/202662.15 USD
5/28/202661.81 USD
5/27/202661.49 USD
5/26/202662.41 USD
5/22/202662.82 USD
5/21/202662.56 USD
5/20/202661.72 USD
5/19/202662.09 USD
5/18/202662.28 USD
5/15/202660.58 USD
5/14/202661.93 USD
5/13/202659.93 USD
5/12/202662.34 USD
5/11/202662.57 USD
5/8/202663.75 USD
5/6/202663.96 USD
5/4/202665.30 USD
5/1/202664.70 USD
4/30/202664.67 USD
4/29/202663.91 USD
4/28/202664.27 USD
4/27/202664.71 USD
4/24/202665.31 USD
4/23/202664.78 USD
4/22/202665.73 USD
4/21/202666.37 USD
4/20/202666.96 USD
4/17/202667.63 USD
4/16/202666.55 USD
4/15/202665.47 USD
4/14/202664.98 USD
4/13/202664.94 USD
4/10/202663.00 USD
4/9/202664.39 USD
4/8/202666.00 USD
4/7/202666.42 USD
4/6/202666.04 USD
4/2/202666.43 USD
4/1/202665.10 USD
3/31/202665.26 USD
3/30/202664.76 USD
3/27/202664.32 USD
3/26/202665.77 USD
3/25/202665.41 USD
3/24/202663.69 USD
3/23/202665.10 USD
3/20/202664.83 USD
3/19/202664.34 USD
3/18/202664.34 USD
3/17/202666.67 USD
3/16/202666.64 USD
3/13/202666.34 USD
3/12/202666.92 USD
3/11/202666.92 USD
3/10/202667.86 USD
3/9/202669.26 USD
3/6/202669.71 USD
3/5/202668.47 USD
3/4/202668.73 USD
3/3/202668.65 USD
3/2/202668.07 USD
2/27/202669.80 USD
2/26/202669.86 USD
2/25/202666.45 USD
2/24/202667.26 USD
2/23/202667.37 USD
2/20/202670.17 USD
2/19/202669.82 USD
2/18/202670.56 USD
2/17/202668.42 USD
2/13/202669.23 USD
2/12/202668.33 USD
2/11/202670.05 USD
2/10/202673.13 USD
2/9/202673.35 USD
2/6/202673.34 USD
2/5/202671.66 USD
2/4/202673.06 USD
2/3/202674.02 USD
2/2/202681.01 USD
1/30/202681.94 USD
1/29/202681.07 USD
1/28/202681.82 USD
1/27/202682.38 USD
1/26/202683.43 USD
1/23/202682.66 USD
1/22/202683.15 USD
1/21/202682.84 USD
1/20/202682.21 USD
1/16/202683.77 USD
1/15/202684.29 USD
1/14/202684.05 USD
1/13/202682.81 USD
1/12/202683.98 USD
1/9/202683.51 USD
1/8/202684.07 USD
1/7/202682.67 USD
1/6/202681.92 USD
1/5/202681.04 USD
1/2/202680.16 USD
12/31/202580.51 USD
12/30/202581.27 USD
12/29/202581.23 USD
12/26/202581.73 USD
12/24/202581.35 USD
12/23/202580.30 USD
12/22/202580.10 USD
12/19/202580.48 USD
12/18/202579.86 USD
12/17/202579.71 USD
12/16/202579.63 USD
12/15/202578.77 USD
12/12/202579.35 USD
12/11/202578.82 USD
12/10/202578.35 USD
12/9/202577.15 USD
12/8/202577.00 USD
12/5/202577.07 USD
12/4/202576.45 USD
12/3/202575.98 USD
12/2/202574.95 USD
12/1/202575.55 USD
11/28/202576.48 USD
11/26/202576.05 USD
11/25/202576.41 USD
11/24/202575.37 USD
11/21/202576.17 USD
11/20/202574.98 USD
11/19/202575.39 USD
11/18/202576.02 USD
11/17/202575.05 USD
11/14/202577.74 USD
11/13/202576.91 USD
11/12/202577.36 USD
11/11/202584.01 USD
11/10/202585.49 USD
11/7/202584.57 USD
11/6/202583.66 USD
11/5/202583.97 USD
11/4/202583.49 USD
11/3/202584.13 USD
10/31/202584.26 USD
10/30/202583.85 USD
10/29/202584.16 USD
10/28/202584.40 USD
10/27/202584.27 USD
10/24/202583.43 USD
10/23/202583.52 USD
10/22/202583.83 USD
10/21/202583.71 USD
10/20/202582.64 USD
10/17/202582.94 USD
10/16/202582.49 USD
10/15/202582.43 USD
10/14/202583.66 USD
10/13/202581.44 USD
10/10/202581.07 USD
10/9/202581.80 USD
10/8/202582.36 USD
10/7/202582.42 USD
10/6/202582.43 USD
10/3/202582.62 USD
10/2/202582.11 USD
10/1/202581.27 USD
9/30/202582.05 USD
9/29/202581.46 USD
9/28/202581.46 USD
9/25/202581.63 USD
9/24/202581.20 USD
9/23/202583.21 USD
9/22/202584.62 USD
9/19/202583.80 USD
9/18/202584.49 USD
9/17/202584.08 USD
9/16/202583.98 USD
9/15/202584.18 USD
9/12/202585.10 USD
9/11/202585.33 USD
9/10/202583.89 USD
9/9/202585.75 USD
9/8/202585.80 USD
9/5/202585.56 USD
9/4/202584.60 USD
9/3/202584.62 USD
9/2/202584.42 USD
8/29/202585.58 USD
8/28/202584.59 USD
8/27/202587.13 USD
8/26/202586.54 USD
8/25/202587.20 USD
8/22/202588.29 USD
Access this data via the Eulerpool API

Amdocs Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
4.89 B USD
653.99 M USD
540.71 M USD
Jan 1, 2024
5.00 B USD
628.61 M USD
493.20 M USD
Jan 1, 2025
4.53 B USD
823.36 M USD
564.70 M USD
Jan 1, 2026 (e)
4.70 B USD
715.40 M USD
813.25 M USD
Jan 1, 2027 (e)
4.85 B USD
741.39 M USD
880.04 M USD
Jan 1, 2028 (e)
5.08 B USD
773.95 M USD
1.00 B USD
Jan 1, 2029 (e)
5.28 B USD
804.81 M USD
1.11 B USD
Jan 1, 2030 (e)
5.49 B USD
836.96 M USD
1.22 B USD

Amdocs Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 22, 2026, 8:50 PM
 
REVENUEB USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB USD
EBITM USD
EBIT MARGIN%
NET INCOMEB USD
NET INCOME GROWTH%
DIV.USD
DIV. GROWTH%
SHARESM
201520162017201820192020202120222023202420252026e2027e2028e2029e2030e
3.643.723.873.974.094.174.294.584.895.004.534.704.855.085.285.49
2.252.064.012.772.822.032.856.726.802.39-9.433.623.284.763.983.99
35.5235.2335.1434.7035.0733.8934.4435.3835.3435.0736.5836.5836.5836.5836.5836.58
1.291.311.361.381.431.411.481.621.731.761.661.721.771.861.932.01
515.00483.00517.00428.00569.00594.00609.00664.00653.00628.00823.00715.00741.00773.00804.00836.00
14.1412.9913.3710.7713.9314.2514.2014.5113.3612.5518.1615.2315.2815.2115.2215.22
0.450.410.440.350.480.500.690.550.540.490.560.810.881.001.111.22
5.69-8.306.60-18.8135.313.7638.43-20.20-1.64-8.7014.4044.158.2413.7510.4910.40
0.680.780.881.001.141.311.441.581.741.922.112.232.452.69
9.6814.7112.8213.6414.0014.919.929.7210.1310.349.905.699.879.80
151.58147.15144.24140.51134.73130.45123.69121.50115.42113.44108.51108.51108.51108.51108.51108.51
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Amdocs generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Amdocs retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Amdocs's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Amdocs has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Amdocs's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Amdocs stock margins

The Amdocs margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Amdocs. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Amdocs.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
34.46 %
14.21 %
16.05 %
Jan 1, 2022
35.38 %
14.53 %
12.01 %
Jan 1, 2023
35.35 %
13.38 %
11.06 %
Jan 1, 2024
35.07 %
12.56 %
9.85 %
Jan 1, 2025
36.58 %
18.16 %
12.46 %
Jan 1, 2026 (e)
36.58 %
15.23 %
17.32 %
Jan 1, 2027 (e)
36.58 %
15.28 %
18.14 %
Jan 1, 2028 (e)
36.58 %
15.23 %
19.71 %

Amdocs Stock Revenue, EBIT, Earnings per Share

The Amdocs earnings per share therefore indicates how much revenue Amdocs has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
34.67 USD
4.93 USD
5.57 USD
Jan 1, 2022
37.67 USD
5.47 USD
4.52 USD
Jan 1, 2023
42.35 USD
5.67 USD
4.68 USD
Jan 1, 2024
44.12 USD
5.54 USD
4.35 USD
Jan 1, 2025
41.77 USD
7.59 USD
5.20 USD
Jan 1, 2026 (e)
42.82 USD
6.59 USD
7.42 USD
Jan 1, 2027 (e)
44.24 USD
6.83 USD
8.03 USD
Jan 1, 2028 (e)
46.33 USD
7.13 USD
9.13 USD

Amdocs business model & stock analysis

Amdocs Ltd is a multinational software and service provider, founded in 1982 and headquartered in Chesterfield, Missouri, USA. The company specializes in customer experience solutions for businesses such as telecommunications providers, cable operators, satellite TV broadcasters, and other service providers. Amdocs offers solutions for business process and operations management, customer relationship management (CRM), business intelligence (BI) and analytics, as well as API integration management. The company has established itself as a trusted partner for businesses worldwide. The company's history began in Israel, when a group of engineers had the idea to bypass the strict telecommunications regulations in Israel by developing billing software for telephone services. When their system was successful, the founders recognized the opportunities that lay before them and exported their technology to other countries. In 1985, Amdocs expanded to North America and opened its first office there. The company quickly grew and soon provided solutions to global companies such as AT&T, Vodafone, Singtel, and Orange for their service management needs. In 1998, Amdocs went public on the NASDAQ stock exchange, generating hundreds of millions of dollars in revenue within hours – a testament to the company's success in the industry. Amdocs' business model is based on helping market leaders build profitable customer relationships. The goal is to improve customer interactions, meet expectations better, and streamline processes. These solutions can provide bidirectional contact, enabling customers and service providers to interact in real-time on the same platform. Amdocs' management and service solutions focus on telecommunications services, as well as new customer groups and industries that rely on digital platforms. The company's proprietary problem-oriented approach leads to increased effectiveness and efficiency for customers who choose to work with Amdocs. Amdocs has five main divisions that it covers: 1) Network Services – aiming to provide transport services for telecommunications services. 2) Business Process Management – a comprehensive set of business workflows for customer management, providing solutions for order management, customer service, billing, and invoicing. 3) Customer Management – CRM systems that enable real-time customer engagement and provide information for customer-specific marketing strategies for businesses. 4) Analytics and Big Data Products – BI, predictive analytics, and data warehousing for effective utilization of customer databases and information. 5) Cloud platforms for dialogue and context-related and API integration product management. Amdocs offers a variety of products that function both system-wide and as stand-alone services. Amdocs' key products in the network services division include OSS (Operations Support System) and BSS (Business Support System) software solutions integrated into over 250 service provider systems. Amdocs' business process management solutions enable service providers to have unified management of business processes, while the customer management portfolio offers flexible, scalable CRM solutions. Amdocs' analytics and big data segment supports the consolidation of data from various sources in central data centers to provide insights into complex customer relationships. Amdocs has received several industry awards that confirm the effectiveness of its products and services. Forbes recognized the company as one of the fastest-growing companies in America, and Fortune named it one of the most admired companies in the industry in Asia, Europe, and the USA. The company has also made several acquisitions over the years, predominantly in the USA and Europe. In 2005, Amdocs acquired Qpass, a leading company in the digital products industry, followed by the acquisitions of JacobsRimell in 2008 and Bridgewater Systems in 2012. Overall, Amdocs has established itself as a significant provider of customer experience solutions that are highly valued by many major companies worldwide. With a clear focus on innovation, customer service, and continuous development of tools and systems, Amdocs has revolutionized the telecommunications market and is a key player in the industry.

Amdocs SWOT Analysis

Strengths

1. Established market presence: Amdocs Ltd has built a strong reputation and prominent position in the telecommunications industry.

2. Extensive product portfolio: The company offers a wide range of software and services, including customer experience solutions, cloud-based platforms, and data analytics.

3. Global reach: Amdocs operates in multiple countries, allowing for a diversified revenue stream and access to various markets.

Weaknesses

1. Dependency on key clients: Amdocs relies heavily on a few major clients for a significant portion of its revenue, which poses a risk in case of client loss or downturn in their business.

2. Prone to external market factors: The company's performance can be affected by changes in government regulations, economic conditions, and technological advancements.

3. Limited diversification: Although Amdocs has expanded its product offerings, the majority of its revenue still comes from the telecommunications sector, making it vulnerable to industry-specific challenges.

Opportunities

1. Growing demand for digital transformation: Amdocs can capitalize on the increasing need for companies to adopt digital technologies and enhance their customer experience.

2. Expansion into new industries: The company can explore opportunities in sectors beyond telecommunications, such as financial services and healthcare, to diversify its revenue sources.

3. Potential for strategic partnerships: Collaborating with other technology companies or industry leaders can enable Amdocs to access new markets, expand its offerings, and enhance its competitive advantage.

Threats

1. Intense competition: Amdocs faces fierce competition from other software providers and service vendors in the telecommunications industry, leading to pricing pressures and potential loss of market share.

2. Rapid technological advancements: The need to constantly upgrade and adapt its solutions to keep pace with emerging technologies is a challenge that Amdocs must address to remain competitive.

3. Data security and privacy concerns: As the company deals with sensitive customer data, any breach or mishandling of information can damage its reputation and result in legal implications.

Amdocs Employees

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Amdocs Employees
Details
Date
Amdocs Employees
Jan 1, 2018
- Employees
Jan 1, 2019
- Employees
Jan 1, 2020
- Employees
Jan 1, 2021
- Employees
Jan 1, 2022
- Employees
Jan 1, 2023
- Employees
Jan 1, 2024
- Employees
Jan 1, 2025
- Employees

Amdocs Segments

Amdocs Revenue by Segment

  • 3 Years

  • Max

Managed services arrangements
Other
Others Member
Details
Date
Managed services arrangements
Other
Others Member
Jan 1, 2021
2.55 B USD
1.74 B USD
0.00 USD
Jan 1, 2022
2.76 B USD
1.82 B USD
0.00 USD
Jan 1, 2023
2.86 B USD
2.03 B USD
0.00 USD
Jan 1, 2024
2.90 B USD
0.00 USD
2.10 B USD
Jan 1, 2025
3.00 B USD
0.00 USD
1.54 B USD

Amdocs Revenue by Region

  • 3 Years

  • Max

North America (mainly United States)
North America
International
Europe
Details
Date
North America (mainly United States)
North America
International
Europe
Jan 1, 2021
0.00 USD
2.79 B USD
874.39 M USD
622.78 M USD
Jan 1, 2022
3.10 B USD
0.00 USD
894.47 M USD
582.19 M USD
Jan 1, 2023
3.31 B USD
0.00 USD
877.42 M USD
703.14 M USD
Jan 1, 2024
3.33 B USD
0.00 USD
952.80 M USD
726.23 M USD
Jan 1, 2025
2.98 B USD
0.00 USD
844.25 M USD
705.11 M USD

Amdocs Eulerpool Fair Value

Details

Fair Value Estimate

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Amdocs historical P/E ratio, EBIT multiple, and P/S ratio

Amdocs annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Amdocs shares outstanding

The number of shares of Amdocs was 108.51 M in 2025. This indicates how many shares Amdocs is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
123.69 M Stocks
Jan 1, 2022
121.50 M Stocks
Jan 1, 2023
115.42 M Stocks
Jan 1, 2024
113.44 M Stocks
Jan 1, 2025
108.51 M Stocks
Jan 1, 2026 (e)
108.51 M Stocks
Jan 1, 2027 (e)
108.51 M Stocks
Jan 1, 2028 (e)
108.51 M Stocks

Amdocs Dividend History

15 years of dividend payments · 13 consecutive increases

YearAnnual DividendYoY ChangePayments
20261.71USDYTD
Mar 31, 20260.57USD 8.0%1/3
Jun 30, 20260.57USD 0.0%2/3
Sep 30, 2026Declared0.57USD 0.0%3/3
20252.11USD 10.0%
Mar 31, 20250.53USD 10.0%1/4
Jun 30, 20250.53USD 0.0%2/4
Sep 30, 20250.53USD 0.0%3/4
Dec 31, 20250.53USD 0.0%4/4
20241.92USD 10.1%
20231.74USD 10.1%
20221.58USD 9.7%
20211.44USD 9.9%
20201.31USD 14.9%
20191.14USD 14.0%
20181.00USD 13.6%
20170.88USD 12.8%

Amdocs dividend history and estimates

In 2025, Amdocs paid a dividend amounting to 2.11 USD. Dividend means that Amdocs distributes a portion of its profits to its owners.
  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2021
1.44 USD
0.00 USD
Jan 1, 2022
1.58 USD
0.00 USD
Jan 1, 2023
1.74 USD
0.00 USD
Jan 1, 2024
1.92 USD
0.00 USD
Jan 1, 2025
2.11 USD
0.00 USD
Jan 1, 2026
2.23 USD
0.00 USD
Jan 1, 2027 (e)
0.00 USD
2.45 USD
Jan 1, 2028 (e)
0.00 USD
2.69 USD

Amdocs dividend payout ratio

In 2025, Amdocs had a payout ratio of 40.51%. The payout ratio indicates the percentage of the company's profits that Amdocs distributes as dividends.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
25.87 %
Jan 1, 2022
34.94 %
Jan 1, 2023
37.14 %
Jan 1, 2024
44.07 %
Jan 1, 2025
40.51 %
Jan 1, 2026 (e)
30.12 %
Jan 1, 2027 (e)
30.53 %
Jan 1, 2028 (e)
29.44 %

Current Amdocs forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
1.52 %
Buy
83.33 % (10)
Hold
16.67 % (2)
Sell
0.00 % (0)
12M Price Target
98.94
Last Price
61.40
Currency
USD
12M Return Potential
61.14 %
LTM Return
0 %

Amdocs Analyst Rating Actions

DateFirmActionRatingReliability
5/14/2026
Stifel
Stifel
MaintainedBuy56
2/5/2026
Barclays
Barclays
MaintainedOverweight56
2/4/2026
Stifel
Stifel
MaintainedBuy56
11/13/2025
Wolfe Research
Wolfe Research
DowngradeOutperformPeer Perform
11/12/2025
Stifel
Stifel
MaintainedBuy56
11/12/2025
B of A Securities
B of A Securities
MaintainedBuy66
11/14/2024
Barclays
Barclays
MaintainedOverweight56
11/13/2024
Oppenheimer
Oppenheimer
MaintainedOutperform61
5/9/2024
Citigroup
Citigroup
MaintainedBuy43
5/9/2024
Baird
Baird
MaintainedNeutral56

Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.

Amdocs Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
8/12/20261.86USD-1.19 BUSD-2026 Q3
5/13/20261.78USD-1.18 BUSD-2026 Q2
2/3/20261.78USD-1.17 BUSD-2026 Q1
11/12/20241.72USD-1.28 BUSD-2024 Q4
5/8/20241.62USD-1.26 BUSD-2024 Q2
1/29/20241.58USD-1.26 BUSD-2024 Q1
8/1/20231.52USD-1.25 BUSD-2023 Q3
5/9/20231.47USD-1.23 BUSD-2023 Q2
1/30/20231.33USD-1.19 BUSD-2023 Q1
11/8/20221.30USD-1.18 BUSD-2022 Q4
...

EESG©

Eulerpool ESG Scorecard© for the Amdocs stock

88/100
99
Environment
99
Social
66
Governance
E

Environment

20
Scope 1 - Direct Emissions1,141
Scope 2 - Indirect emissions from purchased energy41,493
Scope 3 - Indirect emissions within the value chain52,030
Total CO₂ emissions42,634
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees33
Percentage of women in management
Percentage of Asian employees25.38
Share of Asian management30.53
Percentage of Hispanic/Latino employees4.33
Hispano/Latino Management share3.05
Percentage of Black employees3.44
Black Management Share2.54
Percentage of white employees65.83
White Management Share63.49
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Amdocs shareholder structure

% Name
11.56380%
PZENA INVESTMENT MANAGEMENT LLC
PZENA INVESTMENT MANAGEMENT LLC
10.97647%
Pzena Investment Management, LLC
Pzena Investment Management, LLC
10.41251%
FMR LLC
FMR LLC
10.32783%
Fidelity Management & Research Company LLC
Fidelity Management & Research Company LLC
4.81862%
BEUTEL, GOODMAN & CO LTD.
BEUTEL, GOODMAN & CO LTD.
4.31722%
Beutel, Goodman & Company Ltd.
Beutel, Goodman & Company Ltd.
...

Amdocs Beneficial Ownership Filings (SEC 13D/G)

Free Float
96.6%
Float Shares
-
Shares Outstanding
-
StakeHolderFiling
13.20%
PZENA INVESTMENT MANAGEMENT LLC
PZENA INVESTMENT MANAGEMENT LLC
SEC ↗
11.20%
FMR LLC
FMR LLC
SEC ↗
10.10%
Cox                94-1441976
Cox                94-1441976
SEC ↗
10.06%
Thornburg Investment Management Inc.
Thornburg Investment Management Inc.
SEC ↗
8.60%
Manning & Napier Advisors, Inc.
Manning & Napier Advisors, Inc.
SEC ↗
7.80%
Janus Capital Management LLC
Janus Capital Management LLC
SEC ↗
7.40%
Thomas H. Bailey
Thomas H. Bailey
SEC ↗
6.63%
Abigail P. Johnson
Abigail P. Johnson
SEC ↗
6.14%
Edward C. Johnson 3d
Edward C. Johnson 3d
SEC ↗
5.62%
WILLIAM C. MORRIS
WILLIAM C. MORRIS
SEC ↗

Amdocs Executives and Management Board

13 members · avg. age 64 · 31 % women

Management

SS

Mr. Shuky Sheffer (65)

President, Chief Executive Officer, Director · since 2013

TR

Ms. Tamar Rapaport-Dagim (54)

Chief Financial Officer, Chief Operating Officer

RR

Mr. Rajat Raheja (55)

Division President of Amdocs Development Centre India LLP

MS

Mr. Matthew Smith (53)

Head of Investor Relations, Company Secretary

Board of Directors

AG

Mr. Adrian Gardner (63)

Independent Director

10,000.00 USD
EG

Mr. Eliahu Gelman (67)

Chairman of the Board · since 2002

YK

Ms. Yvette Kanouff (60)

Director

VM

Ms. Veronique Morali (67)

Director

SD

Ms. Sarah Davis (58)

Independent Director

RV

Mr. Rafael de la Vega (74)

Independent Director

Frequently asked questions about Amdocs

Amdocs Ltd is a renowned multinational technology and services company specializing in software and solutions for the telecommunications industry. Their business model revolves around providing comprehensive customer experience solutions, enabling telecom service providers to streamline operations, enhance efficiency, and boost customer satisfaction. Amdocs offers a wide range of products and services, including customer relationship management, revenue management, and digital solutions, tailored to address the unique needs of telecom operators worldwide. With a strong focus on innovation and technology, Amdocs continues to grow as a leader in the telecom industry, delivering cutting-edge solutions and driving digital transformation for their clients.

Amdocs Ltd is primarily active in the telecommunications and media industry.

The main competitors of Amdocs Ltd in the market include companies such as Accenture, CSG Systems International, and Oracle Corporation. These companies offer similar software and services in the telecommunications industry, often competing directly with Amdocs for market share and customer contracts. However, Amdocs Ltd is a leading provider of software and services for communications, media, and entertainment companies globally.

Amdocs Ltd is a renowned global software and services provider. Established in 1982, the company has since become a leading player in the telecommunications and media industry. Amdocs specializes in customer experience solutions, business support systems, and digital advertising solutions. With a strong focus on innovation, Amdocs has consistently delivered cutting-edge technologies and services to help Telecom Service Providers enhance their operations and customer experience. Over the years, Amdocs has built a solid reputation for its expertise, reliability, and dedication to customer satisfaction. Today, it continues to thrive as a trusted partner to numerous companies worldwide.

Some significant milestones achieved by Amdocs Ltd include its founding in 1982, becoming a publicly traded company on the NASDAQ in 1998, and being listed on the Tel Aviv Stock Exchange in 2002. Amdocs has also achieved global recognition for its innovative software and services in the telecommunications industry. The company has consistently expanded its operations and customer base, establishing a strong presence in over 85 countries. Amdocs has garnered numerous awards and accolades for its technological advancements, customer satisfaction, and commitment to excellence. Continual growth, strategic acquisitions, and partnerships have strengthened Amdocs' position as a leading provider of software and technology solutions.

Amdocs Ltd is primarily present in multiple countries and regions across the globe. The company has a strong international presence in countries such as the United States, India, Israel, and the United Kingdom. With extensive operations in over 85 countries, Amdocs provides its innovative software solutions, services, and digital transformation offerings to telecommunications and media companies worldwide. Leveraging its expertise and global footprint, Amdocs has successfully established itself as a trusted partner in the telecom industry, powering advanced customer experience and business support systems for leading service providers around the world.

Amdocs Ltd represents a set of core values and a strong corporate philosophy. Known for its customer-centric approach, Amdocs focuses on delivering exceptional value and innovation to its clients. The company is committed to providing superior technology solutions and services in the telecommunications industry. Amdocs believes in fostering long-term partnerships, promoting teamwork, and nurturing a culture of integrity and excellence. With its global presence and vast experience, Amdocs continuously strives to redefine and shape the future of communication, ensuring its customers' success in this dynamic business landscape.

Analysts currently set an average price target of 97.70 USD for the Amdocs stock (median: 98.94 USD), implying +59.1 % versus the latest price. The consensus is based on 12 analyst ratings.

12 analysts currently rate the Amdocs stock: 10 recommend buying, 2 holding and 0 selling. For 2026, analysts expect Amdocs to generate revenue of 4.70 B USD and earnings per share of 7.49 USD.

Converted at the current exchange rate, the Amdocs share trades at 52.56 EUR (61.40 USD).

The Amdocs share (DOX) is listed on 5 stock exchanges, including: NASDAQ (DOX), Frankfurt (AOS.F), München (AOS.MU), Düsseldorf (AOS.DU), SIX (Zürich) (AOS.SW).

Amdocs Ltd is a multinational provider of software, services, and solutions for communication service providers and digital network operators. The company was founded in 1982 and is headquartered in Chesterfield, Missouri, USA. Amdocs operates in over 90 countries and employs more than 27,000 employees worldwide. Amdocs is divided into three main divisions: the Customer Business Unit, the Network Business Unit, and the International Business Unit. The Customer Business Unit of Amdocs offers software solutions for telecommunications companies to improve their customer relationships. The solutions cover a wide range of tasks, from managing customer contacts to customer service and billing. This includes CRM (Customer Relationship Management), billing, and order management. The Network Business Unit of Amdocs offers solutions for network operators. This involves network testing, troubleshooting, automation of network management processes, and quality assurance of network performance. The International Business Unit of Amdocs offers comprehensive services for telecommunications companies. These include consulting services, end-to-end process analysis, network planning and design, and implementation of software solutions. Amdocs offers its customers a wide range of products and solutions. One of the most well-known products is Amdocs CES (Customer Experience Solution), an industry solution that includes various modules such as CRM, billing, and order management. Amdocs also offers a comprehensive portfolio of cloud solutions that provide customers with a flexible and scalable IT infrastructure. In addition to its industry solutions, Amdocs also offers solutions for implementing digital business processes and meeting customer requirements. These include digital billing solutions and analytics tools for measuring customer experiences and the effectiveness of marketing campaigns. Amdocs' business model is based on the continuous expansion of its innovative services and solutions, as well as its global presence. The company conducts research and development in key areas such as artificial intelligence, cloud technology, and big data to offer innovative solutions to its customers. Amdocs has a strong customer base in the telecommunications sector, including major companies such as AT&T, Vodafone, and Telefonica. Through further development of industry-leading solutions and services, the company is well positioned to strengthen its market position and expand its customer base. In summary, Amdocs is a leading provider of software solutions and services for telecommunications companies. The company is divided into three main divisions and offers its customers a wide range of products and services. Amdocs continuously conducts research and development in key areas to offer innovative solutions to its customers and strengthen its market position.

The expected revenue of Amdocs is 4.70 B USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Amdocs is 813.25 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Amdocs is currently 8.19. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Amdocs stock.

The price-to-sales ratio (P/S) of Amdocs is currently 1.42. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Amdocs stock.

The Eulerpool Quality Score for Amdocs is 5/10.

The ISIN of Amdocs is GB0022569080. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Amdocs is 915119. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Amdocs is DOX. The ticker symbol is used to trade Amdocs shares on the stock exchange.

Over the past 12 months, Amdocs paid a dividend of 2.11 USD . This corresponds to a dividend yield of about 3.43 %. For the coming 12 months, Amdocs is expected to pay a dividend of 2.45 USD.

The current dividend yield of Amdocs is 3.43 %.

Amdocs pays a dividend, distributed in the months of , , , .

Amdocs paid dividends every year for the past 14 years.

For the upcoming 12 months, dividends amounting to 2.45 USD are expected. This corresponds to a dividend yield of 3.99 %.

Amdocs is assigned to the 'Information technology' sector.

To receive the latest dividend of Amdocs from amounting to 0.57 USD, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, Amdocs distributed 1.87 USD as dividends.

The dividends of Amdocs are distributed in USD.

All fundamentals and in-depth analysis of Amdocs

Our stock analysis for Amdocs stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Amdocs. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.